Medical Developments International Limited (MVP.AX)
AUD 0.4
(-2.47%)
AUD 0.4
(-2.47%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 33.14 Million | 32.33 Million | 21.94 Million | 25.27 Million | 22.53 Million | 20.87 Million |
| Cost of Revenue | 35.64 Million | 34.85 Million | 25 Million | 8.59 Million | 8.79 Million | 6.69 Million |
| Gross Profit | -2.5 Million | -2.51 Million | -3.06 Million | 16.67 Million | 13.73 Million | 14.18 Million |
| Operating Expenses | 24.36 Million | 17.75 Million | 12.63 Million | 21.91 Million | 11.86 Million | 13.01 Million |
| Selling, General and Administrative Expenses | 35.36 Million | 17.75 Million | 12.63 Million | 21.37 Million | 11.46 Million | 9.67 Million |
| Research and Development Expenses | - | 236 Thousand | 220 Thousand | 536 Thousand | 396 Thousand | 510 Thousand |
| Other Expenses | -11 Million | 19.09 Million | - | - | - | - |
| Cost and Expenses | 50.01 Million | 52.61 Million | 37.63 Million | 30.51 Million | 20.66 Million | 19.7 Million |
| Operating Income | -16.86 Million | -20.27 Million | -15.69 Million | -5.23 Million | 1.87 Million | 3.17 Million |
| Interest Expense | 86 Thousand | 95 Thousand | 103 Thousand | 121 Thousand | 114 Thousand | 71 Thousand |
| Income Tax Expense | 8.06 Million | -1.88 Million | -3.5 Million | -2.41 Million | -58 Thousand | 513 Thousand |
| Earnings before Tax | -32.92 Million | -7.49 Million | -15.9 Million | -14.97 Million | 321 Thousand | 1.55 Million |
| Net Income | -40.99 Million | -5.6 Million | -12.4 Million | -12.56 Million | 379 Thousand | 1.03 Million |
| Earnings Per Share Basic | -0.46 | -0.07 | -0.17 | -0.18 | 0.01 | 0.02 |
| Earnings Per Share Diluted | -0.46 | -0.07 | -0.17 | -0.18 | 0.01 | 0.02 |
| Weighted Average Shares Outstanding | 88.6 Million | 84.27 Million | 72.42 Million | 69.56 Million | 66.64 Million | 65.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 88.6 Million | 84.27 Million | 72.42 Million | 69.56 Million | 66.97 Million | 66 Million |
| Gross Margin | -0.08 | -0.08 | -0.14 | 0.66 | 0.61 | 0.68 |
| EBIT Margin | -0.89 | -0.53 | -0.58 | -0.06 | 0.20 | 0.21 |
| Profit Margin | -1.24 | -0.17 | -0.57 | -0.50 | 0.02 | 0.05 |
| EBITDA | -29.44 Million | -4.28 Million | -12.86 Million | -11.1 Million | 3.03 Million | 3.88 Million |
| Earnings Before Tax Margin | -0.51 | -0.63 | -0.72 | -0.21 | 0.08 | 0.15 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 33.14 Million | 18.06 Million | 15.08 Million | 18.41 Million | 32.33 Million | 13.92 Million |
| Cost of Revenue | 35.64 Million | 15.11 Million | 20.53 Million | 20.14 Million | 34.85 Million | 14.7 Million |
| Gross Profit | -2.5 Million | 2.95 Million | -5.45 Million | -1.73 Million | -2.51 Million | -782 Thousand |
| Operating Expenses | 14.36 Million | 6.82 Million | 7.54 Million | 10.39 Million | 17.75 Million | 7.36 Million |
| Selling, General and Administrative Expenses | - | 6.82 Million | 7.54 Million | 10.39 Million | - | 7.36 Million |
| Research and Development Expenses | - | - | - | 236 Thousand | - | - |
| Other Expenses | - | - | - | - | 19.09 Million | - |
| Cost and Expenses | 50.01 Million | 21.93 Million | 28.08 Million | 30.53 Million | 52.61 Million | 22.07 Million |
| Operating Income | -16.86 Million | -3.86 Million | -12.99 Million | -12.12 Million | -20.27 Million | -8.14 Million |
| Interest Expense | 86 Thousand | 42 Thousand | 44 Thousand | 46 Thousand | 95 Thousand | 49 Thousand |
| Income Tax Expense | 8.06 Million | 9.9 Million | -1.83 Million | -2.74 Million | -1.88 Million | 864 Thousand |
| Earnings before Tax | -32.92 Million | -20.14 Million | -12.78 Million | -11.01 Million | -7.49 Million | 3.52 Million |
| Net Income | -40.99 Million | -30.04 Million | -10.94 Million | -8.26 Million | -5.6 Million | 2.65 Million |
| Earnings Per Share Basic | - | -0.34 | -0.12 | -0.09 | - | 0.03 |
| Earnings Per Share Diluted | - | -0.34 | -0.12 | -0.09 | - | 0.03 |
| Weighted Average Shares Outstanding | 88.6 Million | 88.6 Million | 88.6 Million | 88.6 Million | 84.27 Million | 84.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 88.6 Million | 88.6 Million | 88.6 Million | 88.6 Million | 84.27 Million | 90.99 Million |
| Gross Margin | -0.08 | 0.16 | -0.36 | -0.09 | -0.08 | -0.06 |
| EBIT Margin | - | -0.11 | -0.76 | -0.58 | - | -0.47 |
| Profit Margin | -1.24 | -1.66 | -0.73 | -0.45 | -0.17 | 0.19 |
| EBITDA | - | -2 Million | -11.47 Million | -10.59 Million | - | -6.56 Million |
| Earnings Before Tax Margin | -0.51 | -0.21 | -0.86 | -0.66 | -0.63 | -0.59 |
002824
GEM
CONXF
600211
LABS
TBEV